Now out in @CR_AACR: We mine the epigenetic underpinnings of #AlveolarSoftPartSarcoma utilizing patient samples, preclinical models, and functional tags (dTAG, BioID) to define the oncogenic transcriptional program driven by ASPSCR1::TFE3 and actionable therapeutic liabilities:
My lab is hiring talented and motivated individuals at all levels of training. Our mission is to understand how epigenetic dysregulation drives sarcoma development and plasticity and to translate these insights into new therapies. Please apply at the following links.
Discover the latest research on SDH-deficient GIST and potential new treatment approaches with Dr. Matthew Hemming on November 9 at 12 PM! Register: bit.ly/Understanding-SDH#SDH#GIST#GISTEducation
Three days until Sarcomathon 2026!
Join us a virtually @UMassChan to mark Sarcoma Awareness Month and join a marathon of sarcoma research!
Register at: tinyurl.com/Sarcomathon2026
To mark Sarcoma Awareness Month, @SarcomaLab is hosting Sarcomathon 2026 — a full day of research, awareness, discussion, and action for sarcoma! Join us on Saturday 7/11 for live sarcoma research, Q&As with sarcoma scientists, research demos, and seminars
tinyurl.com/Sarcomathon2026
To mark Sarcoma Awareness Month, @SarcomaLab is hosting Sarcomathon 2026 — a full day of research, awareness, discussion, and action for sarcoma! Join us on Saturday 7/11 for live sarcoma research, Q&As with sarcoma scientists, research demos, and seminars
tinyurl.com/Sarcomathon2026
Our lab is recruiting both a postdoc and research technician to start in May/June! If you know anyone interested in investigating mechanisms of metastasis and immune suppression in cancer through developing innovative mouse models and studying senescence, please spread the word!
Fred Hutch and the University of Washington are jointly recruiting a Director of Clinical Research for #Sarcoma — a physician-scientist ready to lead a collaborative sarcoma clinical research program across our institutions. Learn more and apply: bit.ly/4tf6kVr#hiring
Federal funding for US biomedical research is moribund.
Since October 1 2025, NIH is -80% in new grants and -70% in values (total dollars).
Labs are closing down and researchers are leaving science.
To what end?
SFA is accepting applications for the 2026 Last Mile Sarcoma Research Award. This one-year, $150,000 grant supports sarcoma researchers seeking to strengthen the resubmission of R01 or equivalent proposals focused on advancing the understanding and treatment of sarcoma. Applications are due by February 2, 2026, at 5:00 pm ET.
#sarcoma#curesarcoma#sarcomaresearch